Alaunos Therapeutics to effect 1-for-10 reverse stock split on July 17, 2024

Alaunos Therapeutics, Inc.

Board approved 1-for-10 reverse split; authorized by shareholders on June 6, 2024.
Effective 5:00 p.m. ET July 17, 2024; every 10 pre-split shares become 1 share.
Stock to trade on Nasdaq under symbol TCRT with new CUSIP 98973P309.
Equiniti Trust Company appointed as exchange agent for the split.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.